Skip to content
Biodatica
Start free

Accufy Diagnostics, Inc.

ROCKVILLE, MD · also filed as None

OncologyvaccineFormed
Compare Sign in to watch

What changed

$200k raise filed (Form D)

9mo agoRaise filed (Form D)Oct 2, 2025Source filing (opens the source filing in a new tab)

Momentum

47no change

Momentum 47 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

~0months

The model puts this company near the end of its last raise.

Stage

Formed

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Filing

    Form D · $200k

    Oct 2, 2025

    Accufy Diagnostics, Inc. · private raise, self-reported by the issuer

    SEC EDGAR · 0002089723-25-000001 (opens the source filing in a new tab)

  2. Grant

    K99 · $156k · non-dilutive

    Jul 1, 2025

    UNIVERSITY OF CALIFORNIA BERKELEY · PI HUNG, JESSICA · NCI · award ends Jun 30, 2027 · Decoding therapeutic, cross-presented tumor antigens in pancreatic cancer

    NIH RePORTER · NIH RePORTER 11214404 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources